Article
RNASET2 as a tumor antagonizing gene in a melanoma cancer model.
Department of Biotechnology and Molecular Sciences, University of Insubria, Varese, Italy.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (impact factor:
1.3).
02/2008;
17(2):69-74.
pp.69-74
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Direct inhibition of RNAse T2 expression by the HTLV-1 viral protein Tax.
[show abstract] [hide abstract]
ABSTRACT: Adult T-cell leukemia (ATL) is one of the primary diseases caused by Human T-cell Leukemia Virus type 1 (HTLV-1) infection. The virally-encoded Tax protein is believed to initiate early events in the development of this disease, as it is able to promote immortalization of T-cells and transformation of other cell types. These processes may be aided by the ability of the viral protein to directly deregulate expression of specific cellular genes through interactions with numerous transcriptional regulators. To identify gene promoters where Tax is localized, we isolated Tax-DNA complexes from an HTLV-1-infected T-cell line through a chromatin immunoprecipitation (ChIP) assay and used the DNA to probe a CpG island microarray. A site within the RNASET2 gene was found to be occupied by Tax. Real-time PCR analysis confirmed this result, and transient expression of Tax in uninfected cells led to the recruitment of the viral protein to the promoter. This event correlated with a decrease in the level of RNase T2 mRNA and protein, suggesting that Tax represses expression of this gene. Loss of RNase T2 expression occurs in certain hematological malignancies and other forms of cancer, and RNase T2 was recently reported to function as a tumor suppressor. Consequently, a reduction in the level of RNase T2 by Tax may play a role in ATL development.Viruses 08/2011; 3(8):1485-500. · 1.50 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
activation
common general pathway
growing category
possible role
responsible locus
RNASET2 gene
senescence program
tumor antagonizing/malignancy suppressor genes
tumorigenesis